Dr. Ueli Gubler

SENIOR RESEARCH ASSOCIATE
School: Schaefer School of Engineering & Science
Department: Chemistry and Chemical Biology
Email: ugubler@stevens.edu
Education

1966 ‑ 1970   Gymnasium Berne, Switzerland

1970 ‑ 1976   M.Sc., University of Berne, Switzerland (Major:  General Microbiology)

1976 ‑ 1979   Ph.D. in General Microbiology – University of Berne, Switzerland

Research

Over 30 years  experience in the field of molecular cloning and expression of proteins (some concentration on cytokines), as well as their  biological and biochemical characterization.  

Google Scholar: 

https://scholar.google.com/citations?hl=en&user=sLdOiegAAAAJ

General Information

1980 ‑ 1981  Roche Institute of Molecular Biology PostdoctoralFellow

1981-2012  Hoffmann-La Roche Inc., Nutley NJ - held several positions in preclinical research; last position was Senior Leader and Head of the Biotechnology Section within the Discovery Technology Department  

 

Appointments

Analytical  Biochemistry, Molecular Biology and Recombinant DNA Techniques. Reviewing Editor: 1990 - 1993; Executive Editor: 1993 –

Patents & Inventions

US patent # 5,936,066, Recombinant Human Interleukin-1 alpha”

US patent # 5,536,657,   “Recombinant DNA encoding Human Receptor for Interleukin-12”

US patent # 5,840,530,  “DNA encoding receptors for the beta2-chain of human IL-12”

US patent # 5,780,597,  “Monoclonal antibodies to cytotoxic lymphocyte maturation factor”

US patent #  5,831,007,  “Human receptor for Interleukin-12”

US patent # 6,683,046, “Purification and Characterization of Cytotoxic Lymphocyte Maturation Factor and Monoclonal Antibodies Thereto”

US patent # 7,776,590, “Stable Cell Lines Expressing HERG”

Courses
  • CH 780 Selected Topics in Biochemistry I